Observational studyNeurosurgical review2025
Clinical characteristics and management of cerebral developmental venous anomalies accompanied with cavernous malformation.
Observational study in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Developmental venous anomalies (DVAs) are common cerebral vascular anomalies that are frequently accompanied by cavernous malformations (CM), with mixed research on whether DVAs increase or decrease the risk of CM bleeding. This retrospective observational study aimed to investigate the clinical characteristics and management of DVAs accompanied by CMs. This study involved the clinical data of all patients with DVAs accompanied with CM from January 2013 to December 2023. A total of 14 patients aged 16-62 years (42.86 ± 14.56), were followed up for 10 to 150 months (53.57 ± 39.15). Twelve patients had a single CM, and two patients had multiple CMs. Nine patients did not experience bleeding, most patients showed no symptom aggravation throughout clinical observation or conservative treatment. Five patients with hemorrhage near the DVAs of the posterior cranial fossa experienced headache or focal neurological dysfunction. Two patients underwent surgery, and three obtained conservative treatment without new severe neurological dysfunction. Multiple de novo CMs formed after hemorrhage in two cases. Hemorrhage around the posterior fossa DVA may be an early signal of de novo CM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.